WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.

Major players such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Divi’s Laboratories, Aurobindo Pharma, Lupin, and Biocon faced market volatility.

A federal judge has blocked a new Arkansas law that would have prohibited pharmacy benefit managers, or PBMs—middlemen companies who set drug prices—from owning ...

Catch all live updates on Indian stock markets here on July 31. Stocks are set to react to Donald Trump's 25% tariff on India.

Pharmexcil Chairman warns of US drug shortages and price hikes due to tariffs on Indian pharmaceutical imports.

Trump's 25% tariff on Indian goods will increase essential drug prices in the US, impacting consumers and healthcare. India ...

A federal judge has temporarily blocked an Arkansas law that would have banned pharmacy benefit managers from owning ...

A former General Motors exec joins Ford to run its commercial fleet division. She will expand its revenue opportunities in ...

Fort Myers-based NeoGenomics reported mixed results for the second quarter. Revenue grew 10% over the year, but the net loss ...

The CVS Pharmacy at Valley Shopping Center at 3320 N. Tracy Blvd. in Tracy permanently closed on July 8. The American ...

We recently published 10 Stocks That Jim Cramer Talked About. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim ...

As Celltrion looks to ward off potential import tariffs, the South Korean company’s odds at acquiring a large-scale drug ...